Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ironwood Pharmaceuti (NQ: IRWD ) 6.265 +0.085 (+1.38%) Streaming Delayed Price Updated: 11:31 AM EDT, Jun 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ironwood Pharmaceuti < Previous 1 2 3 4 5 6 Next > Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday June 21, 2024 Via Benzinga Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) May 21, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 09, 2024 Via Benzinga IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga Ironwood Pharmaceuticals Reports First Quarter 2024 Results May 09, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference May 06, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024 May 01, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks April 30, 2024 As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid. Via InvestorPlace Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call April 25, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD) March 28, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March March 07, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga It’s Time! 3 Failing Biotech Stocks to Sell Right Now March 05, 2024 The biotech industry offers investors unique investment opportunities but these three are biotechs to sell. Via InvestorPlace Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 29, 2024 Via Benzinga Stocks Mixed, Headed For Monthly Wins February 29, 2024 In what appears to be a theme this week, stocks are hesitant midday as investors unpack this morning's jobs and inflation data. Via Talk Markets Topics Economy Exposures Interest Rates Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday? February 29, 2024 Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by 25.5% vs. placebo, but misses on two key secondary endpoints. Via Benzinga Nasdaq Gains 100 Points Following PCE Data February 29, 2024 U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the... Via Benzinga Topics Stocks Exposures US Equities PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture February 29, 2024 Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture. Via InvestorPlace Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All February 29, 2024 The company still plans to ask for approval of its short bowel syndrome treatment. Via Investor's Business Daily Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge February 29, 2024 Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? February 29, 2024 Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 29, 2024 It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! Via InvestorPlace Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) February 29, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference February 23, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire Top 4 Health Care Stocks You May Want To Dump In February February 15, 2024 As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance February 15, 2024 From Ironwood Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.